Proteasome Inhibition: A Novel Approach to Anticancer Therapy

Author： Paul G. Richardson   Teru Hideshima   Kenneth C. Anderson  

Publisher： Adis International

ISSN： 1175-6357

Source： American Journal of Cancer, Vol.3, Iss.5, 2004-01, pp. : 271-279

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bortezomib: proteasome inhibition as an effective anticancer therapy

By Richardson Paul G   Mitsiades Constantine  

Future Oncology, Vol. 1, Iss. 2, 2005-04 ,pp. : 161-167

Future Medicine

Access to resources Recommend Favorite

Inhibition of Mast Cell Activity as a New Approach to Anticancer Therapy

By Ionov I.D.  

International Journal of Radiation Biology, Vol. 60, Iss. 1-2, 1991-07 ,pp. : 287-291

Informa Healthcare

Access to resources Recommend Favorite

Therapeutically targeting the SUMOylation, Ubiquitination and Proteasome pathways as a novel anticancer strategy

By Driscoll James  

Targeted Oncology, Vol. 5, Iss. 4, 2010-12 ,pp. : 281-289

Springer Publishing Company

Access to resources Recommend Favorite

STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers (Review)

By Wang Xiaochun   Crowe Philip J.   Goldstein David   Yang Jia-Lin  

International Journal of Oncology, Vol. 41, Iss. 4, 2012-10 ,pp. : 1181-1191

Spandidos Publications

Access to resources Recommend Favorite

The Endothelin Receptor: A Novel Target for Anticancer Therapy

By Pirtskhalaishvili G.   Nelson J.B.  

American Journal of Cancer, Vol. 1, Iss. 2, 2002-02 ,pp. : 81-91

Adis International

Access to resources Recommend Favorite